Your browser doesn't support javascript.
loading
Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations.
Weersink, Rianne A; Burger, David M; Hayward, Kelly L; Taxis, Katja; Drenth, Joost P H; Borgsteede, Sander D.
Afiliação
  • Weersink RA; Department of Pharmacy, Unit of Pharmacotherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands.
  • Burger DM; Department of Clinical Decision Support, Health Base Foundation, Houten, The Netherlands.
  • Hayward KL; Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Taxis K; Centre for Liver Disease Research, Translational Research Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
  • Drenth JPH; Pharmacy Department, Princess Alexandra Hospital, Brisbane, Australia.
  • Borgsteede SD; Department of Pharmacy, Unit of Pharmacotherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands.
Expert Opin Drug Metab Toxicol ; 16(1): 45-57, 2020 Jan.
Article em En | MEDLINE | ID: mdl-31810397

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Cirrose Hepática Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Cirrose Hepática Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article